Ischemia on PET MPI May Identify Patients With Improvement in Angina and Health Status Post-Revascularization

Krishna K. Patel; John A. Spertus; Suzanne V. Arnold; Paul S. Chan; Kevin F. Kennedy; Philip G. Jones; Firas Al Badarin; James A. Case; Staci Courter; A. Iain McGhie; Timothy M. Bateman

doi:10.1016/j.jacc.2019.06.074

Ischemia on PET MPI May Identify Patients With Improvement in Angina and Health Status Post-Revascularization

Krishna K. Patel, John A. Spertus, Suzanne V. Arnold, Paul S. Chan, Kevin F. Kennedy, Philip G. Jones, Firas Al Badarin, James A. Case, Staci Courter, A. Iain McGhie, Timothy M. Bateman

Research output: Contribution to journal › Letter › peer-review

13 Scopus citations

Original language	English
Pages (from-to)	1734-1736
Number of pages	3
Journal	Journal of the American College of Cardiology
Volume	74
Issue number	13
DOIs	https://doi.org/10.1016/j.jacc.2019.06.074
State	Published - 1 Oct 2019

Access to Document

10.1016/j.jacc.2019.06.074

Cite this

Patel, K. K., Spertus, J. A., Arnold, S. V., Chan, P. S., Kennedy, K. F., Jones, P. G., Al Badarin, F., Case, J. A., Courter, S., McGhie, A. I., & Bateman, T. M. (2019). Ischemia on PET MPI May Identify Patients With Improvement in Angina and Health Status Post-Revascularization. Journal of the American College of Cardiology, 74(13), 1734-1736. https://doi.org/10.1016/j.jacc.2019.06.074

@article{cb02133c8ac24067911cebd516ae2d93,

title = "Ischemia on PET MPI May Identify Patients With Improvement in Angina and Health Status Post-Revascularization",

author = "Patel, {Krishna K.} and Spertus, {John A.} and Arnold, {Suzanne V.} and Chan, {Paul S.} and Kennedy, {Kevin F.} and Jones, {Philip G.} and {Al Badarin}, Firas and Case, {James A.} and Staci Courter and McGhie, {A. Iain} and Bateman, {Timothy M.}",

note = "Funding Information: Please note: The ASPIRE study was funded by Blue Cross Blue Shield of Kansas City. The funding agency had no role in design, conduct or reporting of the study. Drs. Patel and Al Badarin are supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number T32HL110837. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr. Spertus has received research grant support from Abbott Vascular and Novartis; is the Principal Investigator of an analytic center for the American College of Cardiology; has served as a consultant to United Healthcare, Bayer, Janssen, AstraZeneca, and Novartis; has an equity interest in Health Outcomes Sciences; owns the copyright to the Seattle Angina Questionnaire; and serves as a board member for Blue Cross Blue Shield of Kansas City. Dr. Case has an equity interest in Cardiovascular Imaging Technologies; and has intellectual property rights for Imagen PET and SPECT software. Dr. Bateman has received research grant support from Bracco, Jubilant, Astellas, and GE Healthcare; has served as a consultant to Curium and GE Healthcare; has an equity interest in Cardiovascular Imaging Technologies; and has intellectual property rights for Imagen PET and SPECT software. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. (Effectiveness Study of Single Photon Emission Computed Tomography [SPECT] Versus Positron Emission Tomography [PET] Myocardial Perfusion Imaging [ASPIRE]; NCT00976053 ). Funding Information: Please note: The ASPIRE study was funded by Blue Cross Blue Shield of Kansas City. The funding agency had no role in design, conduct or reporting of the study. Drs. Patel and Al Badarin are supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number T32HL110837. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr. Spertus has received research grant support from Abbott Vascular and Novartis; is the Principal Investigator of an analytic center for the American College of Cardiology; has served as a consultant to United Healthcare, Bayer, Janssen, AstraZeneca, and Novartis; has an equity interest in Health Outcomes Sciences; owns the copyright to the Seattle Angina Questionnaire; and serves as a board member for Blue Cross Blue Shield of Kansas City. Dr. Case has an equity interest in Cardiovascular Imaging Technologies; and has intellectual property rights for Imagen PET and SPECT software. Dr. Bateman has received research grant support from Bracco, Jubilant, Astellas, and GE Healthcare; has served as a consultant to Curium and GE Healthcare; has an equity interest in Cardiovascular Imaging Technologies; and has intellectual property rights for Imagen PET and SPECT software. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. (Effectiveness Study of Single Photon Emission Computed Tomography [SPECT] Versus Positron Emission Tomography [PET] Myocardial Perfusion Imaging [ASPIRE];NCT00976053).",

year = "2019",

month = oct,

day = "1",

doi = "10.1016/j.jacc.2019.06.074",

language = "English",

volume = "74",

pages = "1734--1736",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier USA",

number = "13",

}

Patel, KK, Spertus, JA, Arnold, SV, Chan, PS, Kennedy, KF, Jones, PG, Al Badarin, F, Case, JA, Courter, S, McGhie, AI & Bateman, TM 2019, 'Ischemia on PET MPI May Identify Patients With Improvement in Angina and Health Status Post-Revascularization', Journal of the American College of Cardiology, vol. 74, no. 13, pp. 1734-1736. https://doi.org/10.1016/j.jacc.2019.06.074

TY - JOUR

T1 - Ischemia on PET MPI May Identify Patients With Improvement in Angina and Health Status Post-Revascularization

AU - Patel, Krishna K.

AU - Spertus, John A.

AU - Arnold, Suzanne V.

AU - Chan, Paul S.

AU - Kennedy, Kevin F.

AU - Jones, Philip G.

AU - Al Badarin, Firas

AU - Case, James A.

AU - Courter, Staci

AU - McGhie, A. Iain

AU - Bateman, Timothy M.

N1 - Funding Information: Please note: The ASPIRE study was funded by Blue Cross Blue Shield of Kansas City. The funding agency had no role in design, conduct or reporting of the study. Drs. Patel and Al Badarin are supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number T32HL110837. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr. Spertus has received research grant support from Abbott Vascular and Novartis; is the Principal Investigator of an analytic center for the American College of Cardiology; has served as a consultant to United Healthcare, Bayer, Janssen, AstraZeneca, and Novartis; has an equity interest in Health Outcomes Sciences; owns the copyright to the Seattle Angina Questionnaire; and serves as a board member for Blue Cross Blue Shield of Kansas City. Dr. Case has an equity interest in Cardiovascular Imaging Technologies; and has intellectual property rights for Imagen PET and SPECT software. Dr. Bateman has received research grant support from Bracco, Jubilant, Astellas, and GE Healthcare; has served as a consultant to Curium and GE Healthcare; has an equity interest in Cardiovascular Imaging Technologies; and has intellectual property rights for Imagen PET and SPECT software. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. (Effectiveness Study of Single Photon Emission Computed Tomography [SPECT] Versus Positron Emission Tomography [PET] Myocardial Perfusion Imaging [ASPIRE]; NCT00976053 ). Funding Information: Please note: The ASPIRE study was funded by Blue Cross Blue Shield of Kansas City. The funding agency had no role in design, conduct or reporting of the study. Drs. Patel and Al Badarin are supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number T32HL110837. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr. Spertus has received research grant support from Abbott Vascular and Novartis; is the Principal Investigator of an analytic center for the American College of Cardiology; has served as a consultant to United Healthcare, Bayer, Janssen, AstraZeneca, and Novartis; has an equity interest in Health Outcomes Sciences; owns the copyright to the Seattle Angina Questionnaire; and serves as a board member for Blue Cross Blue Shield of Kansas City. Dr. Case has an equity interest in Cardiovascular Imaging Technologies; and has intellectual property rights for Imagen PET and SPECT software. Dr. Bateman has received research grant support from Bracco, Jubilant, Astellas, and GE Healthcare; has served as a consultant to Curium and GE Healthcare; has an equity interest in Cardiovascular Imaging Technologies; and has intellectual property rights for Imagen PET and SPECT software. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. (Effectiveness Study of Single Photon Emission Computed Tomography [SPECT] Versus Positron Emission Tomography [PET] Myocardial Perfusion Imaging [ASPIRE];NCT00976053).

PY - 2019/10/1

Y1 - 2019/10/1

UR - http://www.scopus.com/inward/record.url?scp=85072169230&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2019.06.074

DO - 10.1016/j.jacc.2019.06.074

M3 - Letter

C2 - 31558259

AN - SCOPUS:85072169230

SN - 0735-1097

VL - 74

SP - 1734

EP - 1736

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 13

ER -